Table 2.
Variable | Group 1 (n=102) | Group 2 (n=102) | Group 3 (n=104) | Group 4 (n=100) | Group 5 (n=60) | p* |
---|---|---|---|---|---|---|
Platelets (units) | 1 (0, 1) | 1 (0, 2) | 1 (1, 2) | 2 (1, 3) | 3 (1, 4) | |
Mortality at 6 hours (n, %) | 0 (0%) | 0 (0%) | 1 (1%) | 0 (0%) | 55 (92%) | 1.00 |
Mortality at 24 hours (n, %) | 1 (1%) | 2 (2%) | 2 (2%) | 1 (%) | 59 (98%) | 1.00 |
Mortality at 30 days (n, %) | 8 (8%) | 8 (8%) | 8 (8%) | 15 (15%) | 60 (100%) | 0.25 |
Time to death (days) | 3.6 (1.3, 6.3) | 2.8 (0.8, 11.9) | 7.1 (1.5, 18.5) | 8.8 (2.5, 11.2) | 0.09 (0.05, 0.15) | 0.74 |
Other | 1 (1%) | 1 (1%) | 0 (0%) | 1 (1%) | 1 (2%) | |
ICU-free days | 26 (17, 28) | 25 (8, 27) | 22 (11, 26) | 16 (0, 25) | 0 (0, 0) | <0.01 |
AKI (n, %) | 13 (13%) | 17 (17%) | 29 (28%) | 43 (43%) | 2 (3%) | <0.01 |
ARDS (n, %) | 10 (10%) | 14 (14%) | 23 (22%) | 33 (33%) | 5 (8%) | <0.01 |
MOF (n, %) | 0 (0%) | 2 (2%) | 3 (3%) | 14 (14%) | 2 (3%) | <0.01 |
Sepsis (n, %) | 21 (21%) | 26 (25%) | 43 (41%) | 45 (45%) | 0 (0%) | <0.01 |
VTE (n, %) | 7 (7%) | 10 (10%) | 16 (15%) | 14 (14%) | 0 (0%) | 0.20 |
Any complication§ (n, %) | 38 (37%) | 38 (37%) | 61 (59%) | 72 (72%) | 60 (100%) | <0.01 |
for first four groups only
not mutually exclusive
includes mortality, AKI, ARDS, MOF, sepsis, or VTE
RBC, red blood cells; TBI, traumatic brain injury; MOF, multiple organ failure; PE, pulmonary embolism; AKI, acute kidney injury; ARDS, acute respiratory distress syndrome; VTE, venous thromboembolism